Skip to main content
Top
Published in: Reproductive Biology and Endocrinology 1/2017

Open Access 01-12-2017 | Research

A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use

Authors: Norbert Gleicher, Jacob Metzger, Gist Croft, Vitaly A. Kushnir, David F. Albertini, David H Barad

Published in: Reproductive Biology and Endocrinology | Issue 1/2017

Login to get access

Abstract

Background

It has become increasingly apparent that the trophectoderm (TE) at blastocyst stage is much more mosaic than has been appreciated. Whether preimplantation genetic screening (PGS), utilizing a single TE biopsy (TEB), can reliably determine embryo ploidy has, therefore, increasingly been questioned in parallel.

Methods

We for that reason here established 2 mathematical models to assess probabilities of false-negative and false-positive results of an on average 6-cell biopsy from an approximately 300-cell TE. This study was a collaborative effort between investigators at The Center for Human Reproduction in New York City and the Center for Studies in Physics and Biology and the Brivanlou Laboratory of Stem Cell Biology and Molecular Embryology, the latter two both at Rockefeller University in New York City.

Results

Both models revealed that even under best case scenario, assuming even distribution of mosaicism in TE (since mosaicism is usually clonal, a highly unlikely scenario), a biopsy of at least 27 TE cells would be required to reach minimal diagnostic predictability from a single TEB.

Conclusions

As currently performed, a single TEB is, therefore, mathematically incapable of reliably determining whether an embryo can be transferred or should be discarded. Since a single TEB, as currently performed, apparently is not representative of the complete TE, this study, thus, raises additional concern about the clinical utilization of PGS.
Literature
2.
go back to reference Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Florentino F, Gleicher N, Griesinger G, Grifo J, Handyside A, Harper J, Kokkali G, Mastenbroek S, Meldrum D, Meseguer M, Montag M, Munné S, Rienzi L, Rubio C, Scott K, Scott R, Simon C, Swain J, Treff N, Ubaldi F, Vassena R, Vermeesch JR, Verpoest W, Wells D, Geraedtts J. The why, the how and when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists and embryologists. Mol Hum Reprod. 2016;22:845–57.CrossRefPubMed Sermon K, Capalbo A, Cohen J, Coonen E, De Rycke M, De Vos A, Delhanty J, Florentino F, Gleicher N, Griesinger G, Grifo J, Handyside A, Harper J, Kokkali G, Mastenbroek S, Meldrum D, Meseguer M, Montag M, Munné S, Rienzi L, Rubio C, Scott K, Scott R, Simon C, Swain J, Treff N, Ubaldi F, Vassena R, Vermeesch JR, Verpoest W, Wells D, Geraedtts J. The why, the how and when of PGS 2.0: current practices and expert opinions of fertility specialists, molecular biologists and embryologists. Mol Hum Reprod. 2016;22:845–57.CrossRefPubMed
3.
go back to reference Gleicher N, Barad D. A review of, and commentary on the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice. J Assist Reprod Genet. 2012;29(11):1159–66.CrossRefPubMedPubMedCentral Gleicher N, Barad D. A review of, and commentary on the ongoing second clinical introduction of preimplantation genetic screening (PGS) to routine IVF practice. J Assist Reprod Genet. 2012;29(11):1159–66.CrossRefPubMedPubMedCentral
4.
go back to reference Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol. 2014;15:12–22. Gleicher N, Kushnir VA, Barad DH. Preimplantation genetic screening (PGS) still in search of a clinical application: a systematic review. Reprod Biol Endocrinol. 2014;15:12–22.
5.
go back to reference Twisk M, Mastenbroek S, van Wely M, Heineman MJ, Van der Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev. 2006;25(1):CD005291. Twisk M, Mastenbroek S, van Wely M, Heineman MJ, Van der Veen F, Repping S. Preimplantation genetic screening for abnormal number of chromosomes (aneuploidies) in in vitro fertilisation or intracytoplasmic sperm injection. Cochrane Database Syst Rev. 2006;25(1):CD005291.
6.
go back to reference Mastenbroek S, Twisk M, van Echten-Arnds J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NE, Arts EG, de Vries JW, Bossuyr PM, Buys CH, Heineman MJ, Reppings S, van der Veen F. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357(1):9–17.CrossRefPubMed Mastenbroek S, Twisk M, van Echten-Arnds J, Sikkema-Raddatz B, Korevaar JC, Verhoeve HR, Vogel NE, Arts EG, de Vries JW, Bossuyr PM, Buys CH, Heineman MJ, Reppings S, van der Veen F. In vitro fertilization with preimplantation genetic screening. N Engl J Med. 2007;357(1):9–17.CrossRefPubMed
7.
go back to reference Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update. 2011;17(4):454–66.CrossRefPubMed Mastenbroek S, Twisk M, van der Veen F, Repping S. Preimplantation genetic screening: a systematic review and meta-analysis of RCTs. Hum Reprod Update. 2011;17(4):454–66.CrossRefPubMed
8.
go back to reference Gleicher N, Weghofer A, Barad D. Preimplantation genetic screening: “established” and ready for prime time? Fertil Steril. 2008;89:780–8.CrossRefPubMed Gleicher N, Weghofer A, Barad D. Preimplantation genetic screening: “established” and ready for prime time? Fertil Steril. 2008;89:780–8.CrossRefPubMed
9.
go back to reference Mastenbroek S, Repping S. Preimplantation genetic screening: back to the future. Hum Reprod. 2014;29(9):1846–50.CrossRefPubMed Mastenbroek S, Repping S. Preimplantation genetic screening: back to the future. Hum Reprod. 2014;29(9):1846–50.CrossRefPubMed
10.
go back to reference Orvieto R, Shuly Y, Brengauz M, Feldman B. Should preimplantation genetic screening be implemented to routine clinical practice? Gynecol Endocrinol. 2016;32:506–8.CrossRefPubMed Orvieto R, Shuly Y, Brengauz M, Feldman B. Should preimplantation genetic screening be implemented to routine clinical practice? Gynecol Endocrinol. 2016;32:506–8.CrossRefPubMed
11.
go back to reference Gleicher N, Vidali A, Braverman J, Kushnir VA, Barad DH, Hudson C, Wu YG, Wang Q, Zhang L, Albertini DF. Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. Reprod Biol Endocrinol. 2016;14:54.CrossRefPubMedPubMedCentral Gleicher N, Vidali A, Braverman J, Kushnir VA, Barad DH, Hudson C, Wu YG, Wang Q, Zhang L, Albertini DF. Accuracy of preimplantation genetic screening (PGS) is compromised by degree of mosaicism of human embryos. Reprod Biol Endocrinol. 2016;14:54.CrossRefPubMedPubMedCentral
12.
go back to reference Bolton H, Graham SJL, Van der Aa N, Kumar P, Theunis K, Gallardo EF, Voet T, Zernicka-Goetz M. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal development potential. Nat Commun. 2016;7:11165.CrossRefPubMedPubMedCentral Bolton H, Graham SJL, Van der Aa N, Kumar P, Theunis K, Gallardo EF, Voet T, Zernicka-Goetz M. Mouse model of chromosome mosaicism reveals lineage-specific depletion of aneuploid cells and normal development potential. Nat Commun. 2016;7:11165.CrossRefPubMedPubMedCentral
13.
go back to reference Gleicher N, Vidali A, Braverman J, Kushnir VA, Albertini DF, Barad DH. Further evidence against use of PGS in poor prognosis patients: report of normal births after transfer of embryos reported as aneuploid. Fertil Steril. 2015;104 Suppl 3:e9. Gleicher N, Vidali A, Braverman J, Kushnir VA, Albertini DF, Barad DH. Further evidence against use of PGS in poor prognosis patients: report of normal births after transfer of embryos reported as aneuploid. Fertil Steril. 2015;104 Suppl 3:e9.
14.
go back to reference Greco E, Minasi G, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373:2089–90.CrossRefPubMed Greco E, Minasi G, Fiorentino F. Healthy babies after intrauterine transfer of mosaic aneuploid blastocysts. N Engl J Med. 2015;373:2089–90.CrossRefPubMed
15.
go back to reference PGDIS Newsletter, PGDIS Position Statement on Chromosome Mosaicism and Preimplantation Aneuploidy Testing at the Blastocyst Stage, Chicago, Illinois, July 19, 2016. http://www.pgdis.org. Accessed 12 Feb 2017. PGDIS Newsletter, PGDIS Position Statement on Chromosome Mosaicism and Preimplantation Aneuploidy Testing at the Blastocyst Stage, Chicago, Illinois, July 19, 2016. http://​www.​pgdis.​org. Accessed 12 Feb 2017.
17.
go back to reference Deglincerti A, Coft GE, Pietila LN, Zernicka-Goetz M, Siggia ED, Brivanlou AH. Self-organization of the in vitro attached human embryo. Nature. 2016;533(7602):251–4.CrossRefPubMed Deglincerti A, Coft GE, Pietila LN, Zernicka-Goetz M, Siggia ED, Brivanlou AH. Self-organization of the in vitro attached human embryo. Nature. 2016;533(7602):251–4.CrossRefPubMed
18.
go back to reference Hardy K, Stark J, Winston RML. Maintenance of the inner cell mass in human blastocysts from fragmented embryos. Biol Reprod. 2002;68:1165–9.CrossRefPubMed Hardy K, Stark J, Winston RML. Maintenance of the inner cell mass in human blastocysts from fragmented embryos. Biol Reprod. 2002;68:1165–9.CrossRefPubMed
20.
go back to reference Liu E, Escudero T, Ribustello L, Baukman K, Colls P, Munné S. Chromosome abnormalities detected by array comparative genomic hybridization and next-generation sequencing: results on >38,000 embryos, Abstracts of 32nd Annual Meeting of ESHRE, Helsinki, Finland, July 3–6. 2016. p. 601. Liu E, Escudero T, Ribustello L, Baukman K, Colls P, Munné S. Chromosome abnormalities detected by array comparative genomic hybridization and next-generation sequencing: results on >38,000 embryos, Abstracts of 32nd Annual Meeting of ESHRE, Helsinki, Finland, July 3–6. 2016. p. 601.
21.
go back to reference Capalbo A, Ubaldi FM, Cimadomo D, Maggiulli R, Patassini C, Dusi L, Sanges F, Buffo L, Venturella R, Rienzi L. Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies. Hum Reprod. 2016;31(1):199–208.CrossRefPubMed Capalbo A, Ubaldi FM, Cimadomo D, Maggiulli R, Patassini C, Dusi L, Sanges F, Buffo L, Venturella R, Rienzi L. Consistent and reproducible outcomes of blastocyst biopsy and aneuploidy screening across different biopsy practitioners: a multicentre study involving 2586 embryo biopsies. Hum Reprod. 2016;31(1):199–208.CrossRefPubMed
22.
go back to reference Munné S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril. 2010;94:408–30.CrossRefPubMed Munné S, Wells D, Cohen J. Technology requirements for preimplantation genetic diagnosis to improve assisted reproduction outcomes. Fertil Steril. 2010;94:408–30.CrossRefPubMed
23.
go back to reference Albertini DE. On the dichotomy (im)posed by developmental autonomy during early human embryogenesis. J Assist Reprod Genet. 2016;33(7):821–2.CrossRefPubMed Albertini DE. On the dichotomy (im)posed by developmental autonomy during early human embryogenesis. J Assist Reprod Genet. 2016;33(7):821–2.CrossRefPubMed
24.
go back to reference Maheshwari A, Hamilton M, Bhattacharva S. Should we be promoting embryo transfer at blastocyst stage? Reprod Biomed Online. 2016;32(2):1420146. Maheshwari A, Hamilton M, Bhattacharva S. Should we be promoting embryo transfer at blastocyst stage? Reprod Biomed Online. 2016;32(2):1420146.
25.
go back to reference Fritz MA. Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now? Hum Reprod. 2008;23:2617–21.CrossRefPubMed Fritz MA. Perspectives on the efficacy and indications for preimplantation genetic screening: where are we now? Hum Reprod. 2008;23:2617–21.CrossRefPubMed
26.
go back to reference ACOG Committee Opinion No. 430. Preimplantation genetic screening for aneuploidy. Obstet Gynecol. 2009;113:766–7.CrossRef ACOG Committee Opinion No. 430. Preimplantation genetic screening for aneuploidy. Obstet Gynecol. 2009;113:766–7.CrossRef
27.
go back to reference American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril. 2008;90:S136–43. American Society for Reproductive Medicine. Preimplantation genetic testing: a Practice Committee opinion. Fertil Steril. 2008;90:S136–43.
28.
go back to reference Harton G, Braude P, Lashwood A, et al. ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod. 2011;26:14–24.CrossRefPubMed Harton G, Braude P, Lashwood A, et al. ESHRE PGD consortium best practice guidelines for organization of a PGD centre for PGD/preimplantation genetic screening. Hum Reprod. 2011;26:14–24.CrossRefPubMed
29.
go back to reference Fiorentino F, Biricick A, Bono S, Greco E, Minasi MG, Ruberti A, Spinella F. Clinical outcome derived after transfer of embryos with chromosomal mosaicism, Abstracts of the 32nd Annual Meeting of ESHRE, Helsinki, Finland, July3-6. 2016. p. O–028. Fiorentino F, Biricick A, Bono S, Greco E, Minasi MG, Ruberti A, Spinella F. Clinical outcome derived after transfer of embryos with chromosomal mosaicism, Abstracts of the 32nd Annual Meeting of ESHRE, Helsinki, Finland, July3-6. 2016. p. O–028.
30.
go back to reference Garrisi GJ, Walmsley R, Bauckman K, Mendola R, Colls P, Munné S. A small trophectoderm biopsy sample is sufficient to detect most mosaicism after analysis with high resolution next generation sequencing (NGS), Abstracts of the 32nd Annual Meeting of ESHRE, Helsinki, Finland, July 3–6. 2016. p. 642. Garrisi GJ, Walmsley R, Bauckman K, Mendola R, Colls P, Munné S. A small trophectoderm biopsy sample is sufficient to detect most mosaicism after analysis with high resolution next generation sequencing (NGS), Abstracts of the 32nd Annual Meeting of ESHRE, Helsinki, Finland, July 3–6. 2016. p. 642.
31.
go back to reference Kushnir VA, Darmon SK, Albertini DF, Barad DH, Gleicher N. Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012. Fertil Steril. 2016;106(1):75–9.CrossRefPubMed Kushnir VA, Darmon SK, Albertini DF, Barad DH, Gleicher N. Effectiveness of in vitro fertilization with preimplantation genetic screening: a reanalysis of United States assisted reproductive technology data 2011–2012. Fertil Steril. 2016;106(1):75–9.CrossRefPubMed
32.
go back to reference Fragouli E, Alfarawati S, Spath K, Tarozzi N, Borini A, Wells D. The developmental potential of mosaic embryos. Fertil Steril. 2015;104 Suppl 3:e96.CrossRef Fragouli E, Alfarawati S, Spath K, Tarozzi N, Borini A, Wells D. The developmental potential of mosaic embryos. Fertil Steril. 2015;104 Suppl 3:e96.CrossRef
33.
go back to reference Joyner MJ, Paneth N, Ioannidis JPA. What happens when underperforming big ideas in research become entrenched? JAMA. 2016;316:1355–6.CrossRefPubMed Joyner MJ, Paneth N, Ioannidis JPA. What happens when underperforming big ideas in research become entrenched? JAMA. 2016;316:1355–6.CrossRefPubMed
Metadata
Title
A single trophectoderm biopsy at blastocyst stage is mathematically unable to determine embryo ploidy accurately enough for clinical use
Authors
Norbert Gleicher
Jacob Metzger
Gist Croft
Vitaly A. Kushnir
David F. Albertini
David H Barad
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Reproductive Biology and Endocrinology / Issue 1/2017
Electronic ISSN: 1477-7827
DOI
https://doi.org/10.1186/s12958-017-0251-8

Other articles of this Issue 1/2017

Reproductive Biology and Endocrinology 1/2017 Go to the issue